All lobbying filings
Hart Health Strategies
Hart Health Strategies filed a Q1 amendment for Pharmaceutical Research Manufacturers of America on April 18, 2025, reporting no lobbying activity.
Lobbying for Pharmaceutical Research Manufacturers of America
Filing · LD-2 quarterly report
Q1 amendmentNo activity
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Lobbying activity
0
No itemized activity in this filing.